Evidence map›Paper›PMID 36573212›Full record

ReviewNew microbes and new infections2023

Recent advances on human mpox.

Aliya Orassay, Alan Berdigaliyev, Darya Sadvokassova, Ansal Diassova, Amr Amin, Wenwen Cao, Yingqiu Xie

Abstract readReview
In one paragraph

Review in New microbes and new infections, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aliya OrassayDepartment of Biology, School of Sciences and Humanities, Nazarbayev University, Astana, Kazakhstan.
Alan BerdigaliyevDepartment of Biology, School of Sciences and Humanities, Nazarbayev University, Astana, Kazakhstan.
Darya SadvokassovaDepartment of Biology, School of Sciences and Humanities, Nazarbayev University, Astana, Kazakhstan.
Ansal DiassovaDepartment of Biology, School of Sciences and Humanities, Nazarbayev University, Astana, Kazakhstan.
Amr AminBiology Department, UAE University, Al Ain, 15551, United Arab Emirates.
Wenwen CaoRespiratory Department, The Second Affiliated Hospital of Shandong First Medical University, Tai'an, China.
Yingqiu XieDepartment of Biology, School of Sciences and Humanities, Nazarbayev University, Astana, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mpox has been a concern of public health and travel caution. Using databases of WHO, CDC, google scholar, and PubMed, we searched recent literatures and reviewed the history, genomic mutation/evolution, host cell response pathways, regulation policy, vaccine and therapy development. Recent studies showed that current mpox has many genomic mutations related to regulation by APOBEC3. Current mpox has also been suggested to be associated with sexual transmission. Vaccination should be applied and anti-mpox drug should be urgently developed. More investigations are needed to ensure outbreak prevention.

Indexed as

EpidemiologyGlobal healthInfectionMonkeypoxMpoxOutbreakSexual transmission

Identifiers

PMID36573212
PMCPMC9754762

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.